Holymox DM Eye Drop is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone 0.1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections of the eye accompanied by inflammation. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively targeting a wide range of Gram-positive and Gram-negative pathogens. Dexamethasone provides anti-inflammatory action by suppressing the release of inflammatory mediators, reducing ocular swelling, redness, and discomfort. Holymox DM Eye Drop is commonly prescribed for conditions such as bacterial conjunctivitis, keratitis, and postoperative ocular inflammation where infection and inflammation coexist. The combination therapy offers the advantage of simultaneous antimicrobial and anti-inflammatory treatment, promoting faster resolution of symptoms and preventing complications. It should be used under strict medical supervision, with caution in patients with viral or fungal eye infections, as corticosteroids may exacerbate these conditions. Adverse effects may include transient burning or stinging upon instillation, increased intraocular pressure with prolonged use, and potential hypersensitivity reactions. Proper dosing and duration of therapy are essential to minimize resistance development and ensure therapeutic efficacy.